Core Scientific, Inc. $CORZ is Situational Awareness LP’s 5th Largest Position

Situational Awareness LP reduced its stake in Core Scientific, Inc. (NASDAQ:CORZ) by 9.6% during the first quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 26,008,473 shares of the company’s stock after selling 2,748,005 shares during the quarter. Core Scientific makes up approximately 2.8% of Situational Awareness LP’s investment portfolio, making the stock its 5th biggest position. Situational Awareness LP owned approximately 0.08% of Core Scientific worth $389,087,000 as of its most recent filing with the SEC.

Several other institutional investors and hedge funds also recently bought and sold shares of CORZ. Allworth Financial LP grew its holdings in Core Scientific by 206.5% during the third quarter. Allworth Financial LP now owns 1,410 shares of the company’s stock valued at $25,000 after purchasing an additional 950 shares during the period. Larson Financial Group LLC raised its stake in shares of Core Scientific by 936.7% in the fourth quarter. Larson Financial Group LLC now owns 1,866 shares of the company’s stock worth $27,000 after buying an additional 1,686 shares during the period. Osaic Holdings Inc. lifted its position in shares of Core Scientific by 112.1% during the 2nd quarter. Osaic Holdings Inc. now owns 2,017 shares of the company’s stock valued at $34,000 after buying an additional 1,066 shares in the last quarter. Danske Bank A S purchased a new position in shares of Core Scientific during the 4th quarter valued at about $36,000. Finally, PNC Financial Services Group Inc. lifted its position in shares of Core Scientific by 41.3% during the 1st quarter. PNC Financial Services Group Inc. now owns 4,396 shares of the company’s stock valued at $66,000 after buying an additional 1,285 shares in the last quarter.

Core Scientific Stock Up 0.0%

Shares of Core Scientific stock opened at $20.75 on Wednesday. The company has a market capitalization of $6.60 billion, a price-to-earnings ratio of -18.20 and a beta of 5.50. The stock’s 50-day simple moving average is $25.32 and its 200-day simple moving average is $20.77. Core Scientific, Inc. has a 52 week low of $12.60 and a 52 week high of $30.46.

Core Scientific (NASDAQ:CORZ) last released its earnings results on Tuesday, July 28th. The company reported ($3.32) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.06) by ($3.26). The company had revenue of $164.20 million during the quarter, compared to analysts’ expectations of $144.83 million. On average, equities analysts expect that Core Scientific, Inc. will post 0.08 earnings per share for the current year.

More Core Scientific News

Here are the key news stories impacting Core Scientific this week:

• Positive Sentiment: AMD partnership creates significant long-term revenue potential. AMD will secure up to 2.5 gigawatts of Core Scientific data-center capacity for AI deployments. The initial 530-megawatt rollout across five sites is backed by 15-year agreements and could generate approximately $14 billion in potential base contracted revenue. AMD also received warrants to purchase 30 million CORZ shares at $23.47, with vesting tied to successful capacity deployment. Reuters AMD infrastructure partnership article
• Positive Sentiment: Colocation growth reinforces the AI pivot. Second-quarter revenue reached $164.2 million, while colocation revenue reportedly climbed to $136.7 million from $10.6 million a year earlier. The company said adjusted EBITDA was $41.1 million, suggesting improving operating performance despite reported accounting losses. Core Scientific second-quarter results
• Positive Sentiment: Analyst support and bullish options activity added momentum. Needham reaffirmed a Buy rating with a $29 price target, while BTIG maintained Buy with a $38 target. Call-option volume was approximately 55% above its average daily level, indicating increased speculative interest, though options activity is not a guarantee of future gains.
• Neutral Sentiment: Reported earnings contained conflicting signals. Core Scientific posted a $3.32-per-share quarterly GAAP loss, far below consensus, but another earnings measure cited by Zacks showed adjusted EPS of $0.18 versus expectations for a $0.02 loss. The GAAP deficit was reportedly driven largely by noncash warrant fair-value adjustments.
• Negative Sentiment: Execution, dilution and spending risks remain material. Core Scientific incurred approximately $797.5 million in quarterly capital expenditures to convert mining sites for high-density computing. The AMD warrants could dilute shareholders, while an insider’s sale of 10,000 shares and a recent KBW downgrade to Market Perform may temper enthusiasm.

Insiders Place Their Bets

In other Core Scientific news, insider Todd M. Duchene sold 10,000 shares of the company’s stock in a transaction that occurred on Monday, July 20th. The stock was sold at an average price of $22.30, for a total value of $223,000.00. Following the completion of the transaction, the insider directly owned 1,999,101 shares in the company, valued at $44,579,952.30. This represents a 0.50% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. In the last ninety days, insiders sold 80,000 shares of company stock valued at $2,025,400. Corporate insiders own 1.70% of the company’s stock.

Analyst Upgrades and Downgrades

CORZ has been the subject of several analyst reports. Needham & Company LLC reissued a “buy” rating and issued a $29.00 target price on shares of Core Scientific in a report on Tuesday. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Core Scientific in a report on Friday, July 17th. B. Riley Financial upped their price target on shares of Core Scientific from $30.00 to $33.00 and gave the stock a “buy” rating in a research report on Wednesday, May 27th. Jefferies Financial Group upped their price target on shares of Core Scientific from $24.00 to $37.00 and gave the stock a “buy” rating in a research report on Thursday, May 14th. Finally, Freedom Capital raised shares of Core Scientific to a “hold” rating in a research note on Monday, June 15th. One equities research analyst has rated the stock with a Strong Buy rating, fourteen have issued a Buy rating, three have issued a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat.com, Core Scientific currently has a consensus rating of “Moderate Buy” and a consensus price target of $30.39.

Core Scientific Company Profile

Core Scientific, Inc (NASDAQ: CORZ) is a leading provider of large-scale blockchain infrastructure and digital asset mining services. The company develops, owns and operates high-performance data centers optimized for the mining of Bitcoin and other proof-of-work cryptocurrencies. In addition to its core mining operations, Core Scientific offers colocation, hosting and managed services designed to support institutional clients and enterprise users in deploying and scaling blockchain nodes and computing hardware.

Core Scientific’s service portfolio includes hardware procurement, deployment and maintenance, real-time monitoring, power management and network connectivity.